EOG Resources (EOG)

Investing Cash Flow

-$11.05B

TTM · Period ending: · USD

EOG logo

EOG Investing Cash Flow

Latest reported-$11.05B
EOG TTM Cash from Investing (-$253.20M → -$11.05B)
High-resolution chart · PNG

EOG investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

EOG Resources Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-11,051,000,000
-11,051,000,000
-10,936,000,000
-10,450,000,000
-6,048,000,000
-5,800,000,000
-5,967,000,000
-6,190,000,000
-6,161,000,000
-6,370,000,000
-6,340,000,000
-6,238,000,000
-5,922,000,000
-5,667,000,000
-5,056,000,000
-4,496,000,000
-4,213,000,000
-3,554,000,000
-3,419,000,000
-3,218,848,000
-2,620,321,000
-2,637,563,000
-3,347,506,000
-3,907,685,000
-5,029,678,000
-5,817,110,000
-6,177,173,000
-6,272,040,000
-6,604,224,000
-6,604,741,000
-6,170,162,000
-6,110,193,000
-5,357,932,000
-4,607,409,000
-3,987,409,000
-2,744,817,000
-2,090,912,000
-1,520,619,000
-1,252,944,000
-2,038,469,000
-3,334,201,000
-4,084,786,000
-5,320,256,000
-5,927,846,000
-6,268,183,000
-7,494,227,000
-7,513,565,000
-7,682,552,000
-7,540,712,000
-6,978,599,000
-6,314,778,000
-6,204,267,000
-6,151,336,000
-5,903,682,000
-6,119,263,000
-6,426,749,000
-6,014,421,000
-5,702,515,000
-5,754,942,000
-5,284,062,000
-5,267,396,000
-5,290,843,000
-4,902,774,000
-4,388,434,000
-3,892,682,000
-3,429,102,000
-3,414,551,000
-4,118,689,000
-4,712,353,000
-5,184,927,000
-4,966,518,000
-4,362,393,000
-3,740,067,000
-3,404,281,000
-3,455,774,000
-3,410,970,000
-3,252,682,000
-3,010,312,000
-2,710,373,000
-2,391,943,000
-2,091,166,000
-1,859,307,000
-1,678,108,000
-1,581,726,000
-1,535,150,000
-1,490,472,000
-1,396,908,000
-1,584,883,000
-1,540,307,000
-1,384,418,000
-1,268,510,000
-891,329,000
-785,418,000
-799,232,000
-872,538,000
-942,442,000
-1,052,639,000
-1,126,929,000
-1,088,055,000
-1,022,419,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.